WallStreetZen

NYSE: JNJ
Johnson & Johnson Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for JNJ

Based on 12 analysts offering 12 month price targets for Johnson & Johnson.
Min Forecast
$155.00-3.31%
Avg Forecast
$168.92+5.37%
Max Forecast
$182.00+13.54%

Should I buy or sell JNJ stock?

Strong Buy
Strong Buy
8 analysts 66.67%
Buy
1 analysts 8.33%
Hold
3 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Forecast return on equity

Is JNJ forecast to generate an efficient return?
Company
43.86%
Industry
74.22%
Market
62.25%
JNJ's Return on Equity is forecast to be high in 4 years (43.86%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is JNJ forecast to generate an efficient return on assets?
Company
16.57%
Industry
16.87%
Market
19.66%
JNJ is forecast to generate lower Return on Assets (16.57%) than the US Drug Manufacturers - General industry average (16.87%)
Forecast

JNJ earnings per share forecast

What is JNJ's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$8.89+37.57%
Avg 2 year Forecast
$9.74+50.83%
Avg 3 year Forecast
$10.51+62.62%
JNJ's earnings are forecast to grow at a rate of 17.73% per year, which is not exceptional
Forecast

JNJ revenue forecast

What is JNJ's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$88.5B+9.51%
Avg 2 year Forecast
$93.0B+15.05%
Avg 3 year Forecast
$98.4B+21.71%
JNJ's revenue is forecast to grow at a rate of 6.66% per year, which is not exceptional
Forecast

JNJ earnings growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
17.73%
Industry
24.82%
Market
20.47%
JNJ's earnings are forecast to grow slower (17.73% per year) than the US Drug Manufacturers - General industry average (24.82%)
Forecast
JNJ's earnings are forecast to grow slower (17.73% per year) than the US market average (20.47%)
Forecast
JNJ's earnings are forecast to grow faster (17.73% per year) than the risk-free savings rate (1.1%)
Forecast

JNJ revenue growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
6.66%
Industry
6.43%
Market
14.48%
JNJ's revenues are forecast to grow faster (6.66% per year) than the US Drug Manufacturers - General industry average (6.43%)
Forecast
JNJ's revenues are forecast to grow slower (6.66% per year) than the US market average (14.48%)
Forecast

Johnson & Johnson Stock Forecast FAQ

Is Johnson & Johnson Stock a good buy in 2020, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NYSE: JNJ) stock is to Strong Buy JNJ stock.

Out of 12 analysts, 8 (66.67%) are recommending JNJ as a Strong Buy, 1 (8.33%) are recommending JNJ as a Buy, 3 (25%) are recommending JNJ as a Hold, 0 (0%) are recommending JNJ as a Sell, and 0 (0%) are recommending JNJ as a Strong Sell.

What is JNJ's Price Target?

According to 12 Wall Street analysts that have issued a 1 year JNJ price target, the average JNJ price target is $168.92, with the highest JNJ stock price forecast at $182.00 and the lowest JNJ stock price forecast at $155.00.

On average, Wall Street analysts predict that Johnson & Johnson's share price could reach $168.92 by Jan 8, 2022. The average Johnson & Johnson stock price prediction forecasts a potential upside of 5.37% from the current JNJ share price of $160.30.

What is JNJ's earnings growth forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's forecast annual earnings growth rate of 17.73% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 24.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.47%.

Johnson & Johnson's earnings in 2020 is $16,986,000,000.On average, 9 Wall Street analysts forecast JNJ's earnings for 2021 to be $23,397,112,375, with the lowest JNJ earnings forecast at $23,089,861,876, and the highest JNJ earnings forecast at $23,827,052,449. On average, 6 Wall Street analysts forecast JNJ's earnings for 2022 to be $25,652,388,964, with the lowest JNJ earnings forecast at $24,616,899,491, and the highest JNJ earnings forecast at $26,459,875,924.

In 2023, JNJ is forecast to generate $27,657,810,605 in earnings, with the lowest earnings forecast at $26,538,860,628 and the highest earnings forecast at $28,776,760,582.

What is JNJ's revenue growth forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's forecast annual revenue growth rate of 6.66% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.48%.

Johnson & Johnson's revenue in 2020 is $80,856,000,000.On average, 5 Wall Street analysts forecast JNJ's revenue for 2021 to be $233,129,146,805,520, with the lowest JNJ revenue forecast at $230,566,882,999,650, and the highest JNJ revenue forecast at $235,645,599,482,925. On average, 5 Wall Street analysts forecast JNJ's revenue for 2022 to be $244,917,608,649,186, with the lowest JNJ revenue forecast at $241,037,621,959,725, and the highest JNJ revenue forecast at $248,156,776,636,125.

In 2023, JNJ is forecast to generate $259,097,474,586,488 in revenue, with the lowest revenue forecast at $255,902,543,299,575 and the highest revenue forecast at $262,292,405,873,400.

What is JNJ's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's current Earnings Per Share (EPS) is $6.46. On average, analysts forecast that JNJ's EPS will be $8.89 for 2021, with the lowest EPS forecast at $8.77, and the highest EPS forecast at $9.05. On average, analysts forecast that JNJ's EPS will be $9.74 for 2022, with the lowest EPS forecast at $9.35, and the highest EPS forecast at $10.05. In 2023, JNJ's EPS is forecast to hit $10.51 (min: $10.08, max: $10.93).

What is JNJ's forecast return on equity (ROE) for 2021-2024?

(NYSE: JNJ) forecast ROE is 43.86%, which is considered strong.

What is JNJ's forecast return on assets (ROA) for 2021-2024?

(NYSE: JNJ) forecast ROA is 16.57%, which is lower than the forecast US Drug Manufacturers - General industry average of 16.87%.
WallStreetZen
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatistics
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics